Federal Register / Vol. 60, No. 46 / Thursday, March 9, 1995 / Notices 12947

TRANSACTIONS GRANTED EARLY TERMINATION BETWEEN: 021395 AND 022495—Continued

Name of acquiring person, name of acquired person, name of acquired entity PMN No. Date

terminated

K N Energy, Inc., Burlington Resources, Inc., Meridian Oil Hydrocarbons Inc., Meridian Oil Storage .......................... 95–0899 02/14/95

Harnischfeger Industries, Inc., Rochling Industrie Verwaltung GmbH, Jagenberg Papiertechnik GmbH and

Jagenberg Inc ............................................................................................................................................................... 95–0458 02/15/95

The Hillhaven Corporation, The Hillhaven Corporation, The Hillhaven Corporation ...................................................... 95–0987 02/16/95

Shurgard Storage Centers, Inc., Shurgard Incorporated, Shurgard Incorporated .......................................................... 95–0933 02/17/95

American International Group, Inc., Robert H. Ledbetter, Cobb Retail Associates ........................................................ 95–0938 02/17/95

American International Group, Inc., Stephen H. Whisenant, Cobb Retail Associates ................................................... 95–0940 02/17/95

Harvest States Cooperative, H.J. Heinz Company, Portion Pac Inc .............................................................................. 95–0941 02/17/95

Mitsui & Co., Ltd., H.J. Heinz Company, Portion Pac Inc ............................................................................................... 95–0950 02/17/95

Apache Corporation, DEKALB Energy Company, DEKALB Energy Company .............................................................. 95–0964 02/17/95

The Parsons Corporation, Sidney Epstein, A. Epstein and Sons International, Inc ....................................................... 95–0991 02/17/95

WHX Corporation, Ohio Coatings Company (Joint Venture), Ohio Coatings Company (Joint Venture) ....................... 95–0994 02/17/95

Dong Yang Tinplate Ind. Co., Ltd., Ohio Coating Company (Joint Venture), Ohio Coating Company (Joint Venture) . 95–0995 02/17/95

Tostem Corporation, Alumax Inc., Washington Newco and Maryland Newco ............................................................... 95–1010 02/17/95

Mitsui & Co., Ltd., Alumax Inc., Washington Newco and Maryland Newco ................................................................... 95–1011 02/17/95

CPF Acquisition Co., Inc., William H. Kopman, Universal Premium Acceptance Corporation ....................................... 95–0917 02/21/95

The Superior Gen. & Councilors/Franciscan Sisters Mercy, Oklahoma Orthopedic and Arthritis Foundation, Inc.,

Oklahoma Orthopedic and Arthritis Foundation, Inc .................................................................................................... 95–0919 02/21/95

Catholic Healthcare West, Daughters of Charity National Health System, Inc., Daughters of Charity National Health

System-West, Inc ......................................................................................................................................................... 95–0936 02/21/95

K–III Communications Corporation, Jonathan Adler, The Adler Group, Inc, and WJA, Inc ........................................... 95–0973 02/21/95

K–III Communications Corporation, Warren Adler, The Adler Group, Inc., and WJA, Inc ............................................. 95–0974 02/21/95

The Travelers Inc., Warburg Pincus Investors, L.P., HealthSpring, Inc ......................................................................... 95–0975 02/21/95

Metropolitan Life Insurance Company, Warburg Pincus Investors, L.P., HealthSpring, Inc .......................................... 95–0976 02/21/95

Warburg, Pincus Investors, L.P., The Travelers, Inc., The MetraHealth Companies, Inc .............................................. 95–0977 02/21/95

The Jaguar fund N.V., Peter Munk, Clark USA, Inc ....................................................................................................... 95–1005 02/21/95

Tiger (a limited partnership), Peter Munk, Clark USA, Inc .............................................................................................. 95–1009 02/21/95

Credence Systems Corporation, EPRO Corporation, EPRO Corporation ...................................................................... 95–1017 02/21/95

Wictor Forss, E.I. DuPont de Nemours and Company, Conoco ..................................................................................... 95–1018 02/21/95

Svenska Cellulosa Aktiebolaget SCA, Scott Paper Company, Scott Health Care (SHC) Health Care Company

(HCC) ........................................................................................................................................................................... 95–1021 02/21/95

A. Schulman Inc., J.M. Huber Corporation, J.M. Huber Corporation .............................................................................. 95–1027 02/21/95

Fairview Hospital and Healthcare Services, Ebenezer Society, Ebenezer Society ........................................................ 95–1037 02/21/95

Renal Treatment Centers, Inc., Robert I. Falk, Healthcare Corporation ......................................................................... 95–1044 02/21/95

Robert I. Falk, Renal Treatment Centers, Inc., Renal Treatment Centers, Inc .............................................................. 95–1045 02/21/95

Consolidated Electrical Distributors, Inc., Hughes Supply, Inc., Hughes Supply, Inc .................................................... 95–0968 02/22/95

D & K Wholesale Drug, Inc., Krelitz Industries, Inc., Krelitz Industries, Inc ................................................................... 95–1000 02/22/95

Thayer Hotel Investors II L.P., Great Western Financial Corporation, Twinbrook Business Center Incorporated ........ 95–1001 02/22/95

Ricoh Company, Ltd., Savin Corporation, Savin Corporation ......................................................................................... 95–1029 02/22/95

Ronald W. Burkle, Dodi Family L.L.C., Dodi, Inc ............................................................................................................ 95–1038 02/22/95

National Medical Enterprises, Inc., South Dade Health Care Ventures, L.L.C., South Dade Health Care Ventures,

L.L.C ............................................................................................................................................................................. 95–0951 02/23/95

South Miami Health System, Inc., South Dade Health Care Ventures, L.L.C., South Dade Health Care Ventures,

L.L.C ............................................................................................................................................................................. 95–0952 02/23/95

AT&T Corp., LiteSpec Limited Liability Company, LiteSpec Limited Liability Company ................................................ 95–0966 02/23/95

Ira Leon Rennert, UNR Asbestos-Disease Claims Trust, UNR Industries, Inc .............................................................. 95–1028 02/23/95

California Microwave, Inc., Microwave Networks Incorporated, Microwave Networks Incorporated .............................. 95–1007 02/24/95

Arthur W. Epley III, California Microwave, Inc., California Microwave, Inc ..................................................................... 95–1008 02/24/95

Holland Chemical International, B.V., Philip M. Segal, Jr., Worth Chemical Corporation .............................................. 95–1025 02/24/95

American Home Products Corporation, Affymax N.V., Affymax N.V .............................................................................. 95–1049 02/24/95

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay or Renee A. Horton,

Contact Representatives, Federal Trade

Commission, Premerger Notification

Office, Bureau of Competition, Room

303, Washington, D.C. 20580, (202) 326–

3100.

By Direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 95–5788 Filed 3–8–95; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3557]

American Home Products Corporation;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair acts and practices and unfair

method of competition—in connection

with American Home Products

Corporation’s acquisition of American

Cyanamid Company—this consent order

requires, among other things, the New

Jersey-based corporation to divest its

tetanus and diphtheria vaccine business

to a Commission-approved buyer; to

license Cyanamid’s rotavirus vaccine

research to a Commission-approved

licensee; and to change a previously

established licensing agreement to

ensure that it does not obtain certain

competitively sensitive information.

The consent order also prohibits, for ten

years, the respondent from acquiring

any interest in any entity engaged in the

clinical development, manufacture, or

sale of tetanus, diphtheria, or rotavirus

vaccines in the United States without

prior Commission approval.
12948 Federal Register / Vol. 60, No. 46 / Thursday, March 9, 1995 / Notices

1Copies of the Complaint, the Decision and

Order, and Commissioner Azcuenaga’s statement

are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, NW., Washington, DC 20580.

DATES: Complaint and Order issued

February 14, 1995.1

FOR FURTHER INFORMATION CONTACT:

Claudia Higgins or Ann Malester, FTC/

S–2224, Washington, DC 20580. (202)

326–2682.

SUPPLEMENTARY INFORMATION: On

Monday, November 28,1994, there was

published in the Federal Register, 59 FR

60807, a proposed consent agreement

with analysis In the Matter of American

Home Products Corporation, for the

purpose of soliciting public comment.

Interested parties were given sixty (60)

days in which to submit comments,

suggestions or objections regarding the

proposed form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 95–5787 Filed 3–8–95; 8:45 am]

BILLING CODE 6750–01–M

[File No. 951 0002]

Boston Scientific Corporation;

Proposed Consent Agreement With

Analysis To Aid Public Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreement.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair acts and practices and unfair

methods of competition, this consent

agreement, accepted subject to final

Commission approval, would permit,

among other things, Boston Scientific

Corporation, a Massachusetts-based

manufacturer and marketer of catheters,

to proceed with the proposed

acquisitions of Cardiovascular Imaging

Systems, Inc., and SCIMED Life

Systems, Inc., but would require the

respondent to grant a non-exclusive

license to a specified package of patents

and technology related to the

manufacture, production and sale of

intravascular ultrasound (IVUS) imaging

catheters to the Hewlett-Packard

Company or another Commissionapproved licensee. When the consent

becomes final, the license would have to

be granted within ten days to HewlettPackard or within six months to another

licensee. In addition, the consent

agreement would require the respondent

to obtain Commission approval, for ten

years, before acquiring an interest

greater than one percent in a company

engaged in researching, developing or

manufacturing IVUS catheters for sale in

the United States.

DATES: Comments must be received on

or before April 10, 1995.

ADDRESSES: Comments should be

directed to: FTC/Office of the Secretary,

Room 159, 6th St. and Pa. Ave., N.W.,

Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:

Howard Morse or Robert Tovsky, FTS/

S–3627, Washington, D.C. 20580. (202)

326–2949 or 326–2634.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 6(f) of the Federal Trade

Commission Act, 38 Stat. 721, 15 U.S.C.

46 and § 2.34 of the Commission’s Rules

of Practice (16 CFR 2.34), notice is

hereby given that the following consent

agreement containing a consent order to

cease and desist, having been filed with

and accepted, subject to final approval,

by the Commission, has been placed on

the public record for a period of thirty

(30) days. Public comment is invited.

Such comments or views will be

considered by the Commission and will

be available for inspection and copying

at its principal office in accordance with

§ 4.9(b)(6)(ii) of the Commission’s Rules

of Practice (16 CFR 4.9(b)(6)(ii)).

Agreement Containing Consent Order

The Federal Trade Commission

(‘‘Commission’’), having initiated an

investigation of the proposed

acquisitions by Boston Scientific

Corporation of Cardiovascular Imaging

Systems, Inc. and SCIMED Life Systems,

Inc., and it now appearing that Boston

Scientific Corporation, hereinafter

sometimes referred to as ‘‘proposed

respondent,’’ is willing to enter into an

agreement containing an order to license

or divest certain assets, and to cease and

desist from making certain acquisitions,

and providing for other relief:

It Is Hereby Agreed by and between

proposed respondent, by its duly

authorized officers and attorney, and

counsel for the Commission that:

1. Proposed respondent Boston

Scientific Corporation is a corporation

organized, existing and doing business

under and by virtue of the laws of the

State of Delaware with its office and

principal place of business located at 1

Boston Scientific Place, Natick,

Massachusetts, 01760–1537.

2. Proposed respondent admits all the

jurisdictional facts set forth in the draft

of complaint.

3. Proposed respondent waives:

a. Any further procedural steps;

b. The requirement that the

Commission’s decision contain a

statement of findings of fact and

conclusions of law;

c. All rights to seek judicial review or

otherwise to challenge or contest the

validity of the order entered pursuant to

this agreement; and

d. Any claim under the Equal Access

to Justice Act.

4. This agreement shall not become

part of the public record of the

proceeding unless and until it is

accepted by the Commission. If this

agreement is accepted by the

Commission it, together with the draft of

complaint contemplated thereby, will be

placed on the public record for a period

of thirty (30) days and information in

respect thereto publicly released. The

Commission thereafter may either

withdraw its acceptance of this

agreement and so notify the proposed

respondent, in which event it will take

such action as it may consider

appropriate, or issue and serve its

complaint (in such form as the

circumstances may require) and

decision, in disposition of the

proceeding.

5. This agreement is for settlement

purposes only and does not constitute

an admission by proposed respondent

that the law has been violated as alleged

in the draft of complaint, or that the

facts as alleged in the draft complaint,

other than jurisdictional facts, are true.

6. This agreement contemplates that,

if it is accepted by the Commission, and

if such acceptance is not subsequently

withdrawn by the Commission pursuant

to the provisions of § 2.34 of the

Commission’s Rules, the Commission

may, without further notice to the

proposed respondent, (1) issue its

complaint corresponding in form and

substance with the draft of complaint

and its decision containing the

following order to license, divest and

cease and desist in disposition of the

proceeding and (2) make information

public with respect thereto. When so

entered, the order to license, divest and

cease and desist shall have the same

force and effect and may be altered,

modified or set aside in the same

manner and within the same time

provided by statute for other orders. The

order shall become final upon service.

Delivery by the United States Postal

Service of the complaint and decision

containing the agreed-to order to

proposed respondent’s address as stated

in this agreement shall constitute